Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2017, Vol. 13 ›› Issue (02): 244 -248. doi: 10.3877/cma.j.issn.1673-5250.2017.02.024

Special Issue:

Review

Research progress of endometrial hyperplasia

Wuzhi Li1   

  1. 1. Southwest Medical University, Luzhou 646000, Sichuan Province, China
    2. Department of Gynecology and Obstetrics, Mianyang Central Hospital, Mianyagn 621999, Sichuan Province, China
  • Received:2016-12-01 Revised:2017-03-04 Published:2017-04-01
  • About author:
    Corresponding author: Zhang Yong, Email:

With the aging of the population and people′s health needs, standardized diagnosis and treatment of endometrial hyperplasia (EH) are becoming more and more important. EH is a precancerous lesion of endometrial hyperplasia, endometrial hyperplasia and endometrial hyperplasia of the number of irregular hyperplasia of the gland with or without cell. According to the cellular atypia nothing more than hyperplasia, atypical hyperplasia; in 2016 2015, the United States and Britain have issued guidelines for the management of endometrial hyperplasia, the various causes of excessive imbalance of estrogen and progesterone in endometrial estrogen exposure is a risk factor for the occurrence, treatment with progesterone and uterine resection. In this paper, the pathological classification, diagnosis and treatment of endometrial hyperplasia were reviewed.

图1 子宫内膜增生症管理流程
表1 子宫内膜增生症孕激素常用剂型及用法
[1]
Ellenson LH, ed. Blaustein′s pathology of the female genital tract[M]. New York: Springer, 2011: 360.
[2]
Silverberg SG, Kurman RJ, Nogales F, ed. Pathology and genetics of tumours of the breast and female genital organs. World Health Organization classification of tumours[M]. Lyon: IARC, 2003: 221-232.
[3]
Kurman RJ, Carcangiu ML, Herrington CS, ed. WHO classification of tumours of female repro ductive organs. 4th ed[M]. Lyon: IARC, 2014.
[4]
Committee on Gynecologic Practice, Society of Gynecologic Oncology. The American College of Obstetricians and Gynecologists Committee Opinion No. 631. Endometrial intraepithelial neoplasia[J]. Obstet Gynecol, 2015, 125(5): 1272-1278.
[5]
Lacey JV Jr, Sherman ME, Rush BB, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia[J]. J Clin Oncol, 2010, 28(5): 788-792.
[6]
Royal College of Obstetricians and Gynaecologists. Management of endometrial hyperplasia. Green-top guideline No. 67 RCOG/BSGE joint guideline[M]. London: RCOG Press, 2016.
[7]
吴成. 子宫内膜癌的筛查策略[J].中国计划生育学杂志,2012, 20(10): 717-719.
[8]
Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus (part 3 of 4): chapter 7--intrauterine contraception[J]. J Obstet Gynaecol Can, 2016, 38(2): 182-222.
[9]
冷旭,王敏,张淑兰,等. 不同方法获取子宫内膜进行组织学诊断的对照研究[J]. 中华妇产科杂志, 2013, 48(12) : 891-895.
[10]
Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review[J]. JAMA, 2002, 288(13): 1610-1621.
[11]
Leitao MM Jr, Han G, Lee LX, et al. Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk[J]. Am J Obstet Gynecol, 2010, 203(4): 349. e1-e6.
[12]
Costales AB, Schmeler KM, Broaddus R, et al. Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia[J]. Gynecol Oncol, 2014 (135): 451-454.
[13]
Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review[J]. JAMA, 2002, 288(13): 1610-1621.
[14]
Rotenberg O, Renz M, Reimers L, et al. Simultaneous endometrial aspiration and sonohysterography for the evaluation of endometrial pathology in women aged 50 years and older[J]. Obstet Gynecol, 2015, 125(2): 414-423.
[15]
Terakawa N, Kigawa J, Taketani Y, et al. The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group[J]. J Obstet Gynaecol Res, 1997, 23(3): 223-230.
[16]
Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of " untreated" hyperplasia in 170 patients[J]. Cancer, 1985, 56(2): 403-412.
[17]
Committee opinion No. 605: primary ovarian insufficiency in adolescents and young women[J]. Obstet Gynecol, 2014, 124(1): 193-197.
[18]
Amezcua CA, Lu JJ, Felix JC, et al. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia[J]. Gynecol Oncol, 2000, 79(2): 169-176.
[19]
Gallos ID, Yap J, Rajkhowa M, et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and Meta analysis[J]. Am J Obstet Gynecol, 2012, 207(4): 266. e1-e12.
[20]
Emarh M. Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study[J]. Arch Gynecol Obstet, 2015, 292(6): 1339-1343.
[21]
Park JY, Lee SH, Seong SJ, et al. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin[J]. Gynecol Oncol, 2013, 129(1): 7-11.
[22]
Abu Hashim H, Zayed A, Ghayaty E, et al. LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial[J]. J Gynecol Oncol, 2013, 24(2): 128-134.
[23]
Minig L, Franchi D, Boveri S, et al. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women[J]. Ann Oncol, 2011, 22(3): 643-649.
[24]
Kill LM, Kapetanakis V, McCullough AE, et al. Progression of pelvic implants to complex atypical endometrial hyperplasia after uterine morcellation[J]. Obstet Gynecol, 2011, 117(2 Pt 2): 447-449.
[25]
American Association of Gynecologic Laparoscopists. AAGL practice report: practice guidelines for laparoscopic subtotal/supracervical hysterectomy (LSH)[J]. J Minim Invasive Gynecol, 2014, 21(1): 9-16.
[26]
中华医学会妇产科学分会妇科内分泌学组. 异常子宫出血诊断与治疗指南[J]. 中华妇产科杂志, 2014, 49(11): 801-806.
[27]
Kumar S, Bandyopadhyay S, Semaan A, et al. The role of frozen section in surgical staging of low risk endometrial cancer[J]. PLoS One, 2011, 6(9): e21912.
[28]
Moulder JK, Yunker A. Endometrial ablation: considerations and complications[J]. Curr Opin Obstet Gynecol, 2016, 28(4): 261-266.
[29]
Nevadunsky NS, Van Arsdale A, Strickler HD, et al. Metformin use and endometrial cancer survival[J]. Gynecol Oncol, 2014, 132(1): 236-240.
[30]
Xie Y, Wang YL, Yu L, et al. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells[J]. J Steroid Biochem Mol Biol, 2011, 126(3-5): 113-120.
[1] Baicheng Yi, Xuguang Li, Rongrong Wang, Xinxuan Wang. Treatment of calcified root canals in upper anterior teeth using digital 3D-printing guides:A clinical report of two cases[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2024, 18(06): 385-390.
[2] Huayue Yan, Zixiang Liu, Shaobo Zhou. Research progress of phosphoenolpyruvate carboxykinase-1 in malignant tumors[J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(06): 452-456.
[3] Huazhi Li, Guang Cao, Diangang Liu, Yajing Zhang. Clinical comparison of descending hepatectomy with different approaches for primary hepatocellular carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 52-55.
[4] Hao Chen, Meng Wang. Advances in clinicopathological features and treatment options of sig-ring cell carcinoma of the stomach[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 108-111.
[5] Yuefang Xu, Wang Liu, Miaotian Zeng, Yushu Guo. Clinical efficacy of polymyxin B and polymyxin E in the treatment of surgical multi-drug resistant infections Security analysis[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 700-703.
[6] Yifan Li, Diwen Zhu, Weixin Ren, Yingjun Bao, Junpeng Gu, Haixiao Zhang, Gengfei Cao, Weizheng Ji. Role of serum GP73 level in the evaluation of TACE efficacy for primary liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 825-830.
[7] Qiusheng Wang. Diagnosis and treatment strategy for benign biliary diseases[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 779-782.
[8] Anti-Cancer Association China, Committee of Colorectal Cancer CACA the. CACA guidelines for holistic integrative management of anal cancer (2024 Edition)[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 441-449.
[9] Xuefeng Zhou, Zheyi Dong, Zhe Feng, Guangyan Cai, Xiangmei Chen. Formulation protocol of guidelines for diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 301-305.
[10] Bin Shi, Yuan Si. Effect of Yiqiheluo formula combined with valsartan in the treatment of IgA nephropathy with deficiency of both qi and yin plus blood stasis syndrome[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 306-312.
[11] Wenkai Guo, Pengcheng Ji, Jingru Bi, Yuansheng Xie. Ten treatment measures for IgA nephropathy[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 327-333.
[12] Xuan Tie, Xiaole Su, Lihua Wang. Progress of research on the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 345-351.
[13] Tianyu Wu, Zixuan Liu, Puxin Yang, Siming Jia, Kai Ding, Xiaodong Cheng, Yonglong Li, Wei Chen, Hongzhi Lyu, Qi Zhang. Progress in Conservative Treatment of Lumbar Disc Herniation[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2024, 10(06): 379-384.
[14] Qianqian Chen, Chen Yuan, Ji Liu, Tingting Yin. Effects of multi-slice spiral CT parameters,carcinoembryonic antigen,mismatch repair gene,and pathological indicators on prognosis of colorectal cancer[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 507-511.
[15] Xiya Wang, Hongqing Yin, Wei Ding, Bin Xu, Haiyuan Yu, Dongsheng Ma, Jun Shao. Multiparameter analysis of papillary thyroid carcinoma complicated with Hashimoto thyroiditis for predicting high-volume lymph node metastasis[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(06): 548-554.
Viewed
Full text


Abstract